ALISO VIEJO, Calif.--(BUSINESS WIRE)--WaveTec Vision, the leader in wavefront-guided custom cataract™ surgery, announced today that its ORange® intraoperative wavefront aberrometer has been shown to be more predictable in determining refraction in the post-refractive eye, than any other post-LASIK formula currently available.
Wavefront custom cataract aberrometry with ORange is a breakthrough in modern cataract surgery. The technology has been clinically proven to increase accuracy and improve refractive outcomes: 73 percent of procedures are within 0.5D of intended target, versus 58 percent with traditional cataract surgery using standard method biometry.
“Following LASIK, patients expect a lifetime of quality uncorrected vision. Unfortunately, these same patients are the most difficult to predict the optimal IOL power when they develop cataracts,” Eric Donnenfeld, MD said. “WaveTec’s ORange, in my experience and now documented in studies, is the best technology to improve refractive outcomes and overall patient satisfaction in post LASIK eyes.”
A patented diagnostic breakthrough, ORange allows cataract surgeons – for the first time – to measure refraction during surgery, so they can precisely predict and customize how their patients will see following the procedure.
The new post-LASIK coefficients which are part of the recently released ORange v2.6 software upgrade, will greatly improve post operative cataract refractive outcomes for patients having undergone previous corneal refractive surgery.
About WaveTec Vision
WaveTec Vision, a privately held company, is the leader in wavefront-guided custom cataract™ surgery. Their breakthrough intraoperative aberrometer system ORange® is the first to be FDA registered for cataract surgery, offering patients increased accuracy and improved refractive outcomes. For more information on WaveTec and ORange, visit www.wavetecvision.com.